Belotecan/cisplatin versus etoposide/cisplatin in previously untreated patients with extensive-stage small cell lung carcinoma: a multi-center randomized phase III trial

被引：0
|
作者：
In-Jae Oh
Kyu-Sik Kim
Cheol-Kyu Park
Young-Chul Kim
Kwan-Ho Lee
Jin-Hong Jeong
Sun-Young Kim
Jeong-Eun Lee
Kye-Chul Shin
Tae-Won Jang
Hyun-Kyung Lee
Kye-Young Lee
Sung-Yong Lee
机构：
[1] Chonnam National University Hwasun Hospital,Department of Internal Medicine, Lung and Esophageal Cancer Clinic
[2] Yeungnam University Medical Center,Department of Internal Medicine
[3] Yeungnam University College of Medicine,Department of Internal Medicine
[4] Chungnam National University Hospital,Department of Internal Medicine
[5] Chungnam National University School of Medicine,Department of Internal Medicine
[6] Yonsei University Wonju Severance Christian Hospital,Department of Internal Medicine
[7] Yonsei University College of Medicine,Department of Internal Medicine
[8] Kosin University Gospel Hospital,Department of Internal Medicine
[9] Kosin University College of Medicine,undefined
[10] Inje University Busan Paik Hospital,undefined
[11] Konkuk University Medical Center,undefined
[12] Konkuk University School of Medicine,undefined
[13] Guro Hospital,undefined
[14] Korea University,undefined
来源：
BMC Cancer | / 16卷
关键词：
Small cell lung carcinoma; Extensive stage disease; Phase III study; Chemotherapy; First-line; Belotecan;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Belotecan/cisplatin versus etoposide/cisplatin in previously untreated patients with extensive-stage small cell lung carcinoma: a multi-center randomized phase III trial
    Oh, In-Jae
    Kim, Kyu-Sik
    Park, Cheol-Kyu
    Kim, Young-Chul
    Lee, Kwan-Ho
    Jeong, Jin-Hong
    Kim, Sun-Young
    Lee, Jeong-Eun
    Shin, Kye-Chul
    Jang, Tae-Won
    Lee, Hyun-Kyung
    Lee, Kye-Young
    Lee, Sung-Yong
    BMC CANCER, 2016, 16
  • [2] Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer
    Hanna, N
    Bunn, PA
    Langer, C
    Einhorn, L
    Guthrie, T
    Beck, T
    Ansar, R
    Ellis, P
    Byrne, M
    Morrison, M
    Hariharan, S
    Wang, B
    Sandler, A
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (13) : 2038 - 2043
  • [3] Randomized, phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated, extensive-stage, small-cell lung cancer (SCLC)
    Langer, C
    Hanna, N
    Einhorn, L
    Sandler, A
    Ansari, R
    Ellis, R
    Byrne, M
    Green, M
    Morrison, M
    Bunn, P
    LUNG CANCER, 2005, 49 : S53 - S54
  • [4] Randomized phase III trial of cisplatin/irinotecan versus cisplatin/etoposide in patients with extensive-stage small-cell lung cancer
    Lara, Primo N., Jr.
    Gandara, David R.
    Natale, Ronald B.
    CLINICAL LUNG CANCER, 2006, 7 (05) : 353 - 356
  • [5] Randomized, phase III trial comparing irinotecan/cisplatin (IP) with etoposide/cisplatin (EP) in patients (pts) with previously untreated, extensive-stage (ES) small cell lung cancer (SCLC).
    Hanna, NH
    Einhorn, L
    Sandler, A
    Langer, C
    Hariharan, S
    Ansari, R
    Ellis, P
    Byrne, M
    Wang, B
    Bunn, P
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 1094S - 1094S
  • [6] COMPARATIVE STUDY BETWEEN BELOTECAN/CISPLATIN AND ETOPOSIDE/CISPLATIN (COMBAT) IN PATIENTS WITH PREVIOUSLY UNTREATED, EXTENSIVE STAGE SMALL CELL LUNG CANCER
    Oh, In-Jae
    Kim, Kyu-Sik
    Kim, Young-Chul
    Na, Kook-Joo
    Ahn, Sung-Ja
    Song, Sang-Yun
    Choi, Yoo-Duk
    Yoon, Seong-Hoon
    Lee, Boram
    Yu, Jinyeong
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1171 - S1171
  • [7] A phase I and Pharmacologic study of belotecan in combination with cisplatin in patients with previously untreated extensive-stage disease small cell lung cancer
    Lee, Dae Ho
    Kim, Sang-We
    Bae, Kyun-Seop
    Hong, Jeong-Sook
    Suh, Cheolwon
    Kang, Ybon-Koo
    Lee, Jung-Shin
    CLINICAL CANCER RESEARCH, 2007, 13 (20) : 6182 - 6186
  • [8] A phase I and pharmacologic study of belotecan in combination with cisplatin in patients with previously untreated extensive-stage disease small cell lung cancer
    Lee, J.
    Lee, D.
    Bae, K.
    Kim, S.
    Suh, C.
    Shin, J.
    Hong, J.
    Kang, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [9] COMPARATIVE STUDY BETWEEN BELOTECAN/CISPLATIN AND ETOPOSIDE/CISPLATIN (COMBAT) IN PATIENTS WITH PREVIOUSLY UNTREATED, EXTENSIVE STAGE SMALL CELL LUNG CANCER - INTERIM ANALYSIS
    Kim, Y.
    Kim, K.
    Oh, I.
    Ban, H.
    Na, K.
    Ahn, S.
    Kang, H.
    Kim, W.
    Park, C.
    Yang, S.
    ANNALS OF ONCOLOGY, 2012, 23 : 492 - 492
  • [10] Cisplatin Combined with Irinotecan or Etoposide for Untreated Extensive-Stage Small Cell Lung Cancer
    Shi, Yuankai
    Hu, Xingsheng
    Hu, Yi
    Han, Xiaohong
    Li, Xue
    Lin, Lin
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S625 - S625
12345